Publikationen in Zusammenarbeit mit Forschern von University of Belgrade (17)

2024

  1. APS calculator: A data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data

    Clinical Chemistry and Laboratory Medicine, Vol. 62, Núm. 4, pp. 597-607

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2022

  1. An approach for determining allowable between reagent lot variation

    Clinical Chemistry and Laboratory Medicine, Vol. 60, Núm. 5, pp. 681-688

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e25

  3. Improving the laboratory result release process in the light of ISO 15189:2012 standard

    Clinica Chimica Acta

2020

  1. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

    Epidemiology and Psychiatric Sciences

  2. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

    Psychological Medicine, Vol. 50, Núm. 11, pp. 1884-1897

2019

  1. White noise speech illusions: A trait-dependent risk marker for psychotic disorder?

    Frontiers in Psychiatry, Vol. 10, Núm. SEP

2016

  1. The global spread of HIV-1 subtype B epidemic

    Infection, Genetics and Evolution, Vol. 46, pp. 169-179

2015

  1. Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

    PLoS Medicine, Vol. 12, Núm. 4

2014

  1. Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations

    Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736

2013

  1. Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

    HIV Medicine, Vol. 14, Núm. 10, pp. 614-623

2012

  1. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

    Retrovirology, Vol. 9

2009

  1. Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach

    Retrovirology, Vol. 6

2006

  1. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    Journal of Acquired Immune Deficiency Syndromes, Vol. 41, Núm. 3, pp. 352-360

2005

  1. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management

    Journal of Infectious Diseases, Vol. 192, Núm. 6, pp. 958-966